Rauls Velins, Roche’s general manager for Latvia, introduces the company’s longstanding commitment to the Latvian market, Roche’s role in helping facilitate Latvia’s new National Cancer Plan, and the potential for personalized medicine across the Baltics.
Could you please start by introducing Roche in Latvia and the strategic significance of the local affiliate?
"Our main focus will be in oncology and rolling out FMI services including Artificial Intelligence so as to differentiate patient needs and enable targeted therapies."
